Director of Preclinical Development at Xellar Biosystems - Cambridge, Massachusetts, United States
The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.